DRUG-INDUCED THROMBOCYTOPENIA IN PSYCHIATRIC PATIENTS: EARLY RECOGNITION AND CASE-BASED MULTIDISCIPLINARY MANAGEMENT
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Lingua: | inglese |
| Pubblicazione: |
Zenodo
2026
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901064656093184 |
|---|---|
| author | Laleh, Zand Reza |
| author_facet | Laleh, Zand Reza |
| contents | <p>Background and Aim: Drug-induced thrombocytopenia (DIT) is a rare but potentially life-threatening condition triggered by certain medications. This report aims to emphasize the importance of early diagnosis and appropriate management of DIT in patients with Major Depressive Disorder (MDD) treated with a polypharmacy regimen. <br>Case Presentation: A case study of a 39-year-old woman with MDD who developed bleeding following treatment with “aripiprazole”, “olanzapine”, “lorazepam”, and “sodium valproate” is presented. <br>Conclusion: The patient’s condition improved significantly after medication changes and close collaboration between psychiatrists and hematologists. This highlights the need for proper care and correct prescription of medicines for patients with MDD. <br>Laboratory Highlights & Technical Implications: This case report demonstrates the need for: <br>• Enhanced CBC review protocols for patients receiving psychiatric care/treatment who are on polypharmacy; • Reflex testing algorithms for thrombocytopenia (low platelet count) workups; <br>• Standardized communication channels between lab and mental health teams. </p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18936145 |
| institution | Zenodo |
| language | eng |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | DRUG-INDUCED THROMBOCYTOPENIA IN PSYCHIATRIC PATIENTS: EARLY RECOGNITION AND CASE-BASED MULTIDISCIPLINARY MANAGEMENT Laleh, Zand Reza Drug-Induced Thrombocytopenia; Platelet; Major Depressive Disorder (MDD); CBC Monitoring; Antidepressants; Psychotropic Medications/Drugs; Lab-Clinic Collaboration. <p>Background and Aim: Drug-induced thrombocytopenia (DIT) is a rare but potentially life-threatening condition triggered by certain medications. This report aims to emphasize the importance of early diagnosis and appropriate management of DIT in patients with Major Depressive Disorder (MDD) treated with a polypharmacy regimen. <br>Case Presentation: A case study of a 39-year-old woman with MDD who developed bleeding following treatment with “aripiprazole”, “olanzapine”, “lorazepam”, and “sodium valproate” is presented. <br>Conclusion: The patient’s condition improved significantly after medication changes and close collaboration between psychiatrists and hematologists. This highlights the need for proper care and correct prescription of medicines for patients with MDD. <br>Laboratory Highlights & Technical Implications: This case report demonstrates the need for: <br>• Enhanced CBC review protocols for patients receiving psychiatric care/treatment who are on polypharmacy; • Reflex testing algorithms for thrombocytopenia (low platelet count) workups; <br>• Standardized communication channels between lab and mental health teams. </p> |
| title | DRUG-INDUCED THROMBOCYTOPENIA IN PSYCHIATRIC PATIENTS: EARLY RECOGNITION AND CASE-BASED MULTIDISCIPLINARY MANAGEMENT |
| topic | Drug-Induced Thrombocytopenia; Platelet; Major Depressive Disorder (MDD); CBC Monitoring; Antidepressants; Psychotropic Medications/Drugs; Lab-Clinic Collaboration. |
| url | https://doi.org/10.5281/zenodo.18936145 |